The safety measure at stake is “Death Among Surgical Inpatients with Serious Treatable Complications,” also known as Patient Safety Indicator 4, or PSI-4.
Here are five reasons CMS should maintain the safety measure, as outlined by Leapfrog in a June 28 statement:
- PSI-4 is a powerful and important safety measure, and patient safety is one of the most significant death risks Medicare beneficiaries and the public will ever encounter.
- Leapfrog uses PSI-4 in its Leapfrog Hospital Safety Grade and it’s one of the highest priority measures for purchasers and consumers.
- Deaths counted in PSI-4 can be prevented by hospitals; deaths from all causes are not always the fault of the hospital.
- PSI-4 is a surgical measure. There are very few measures that are focused on surgical safety or surgical outcomes in general.
- Improvements to PSI-4 can occur while the current measure continues to be included in the [inpatient quality reporting] and is publicly reported.
More than 75 organizations and individuals signed Leapfrog’s letter to CMS regarding the proposed removal of PSI-4.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
